Skip to main content

View Resource

Published

Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysis.
Huang C. The Lancet Regional Health – Western Pacific 2025;:https://doi.org/10.1016/j.lanwpc.2025.101711.
[Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic. During the pandemic, consumption rates in LMICs and UMICs appeared to slow down, however, patterns of change in psychotropic medication consumption following onset of the pandemic vary on a country level. To address these disparities, strategies for equitable psychotropic medication distribution and enhanced mental health care access in LMICs and UMICs are needed to improve global mental health.]
Freely available online
Age Groups
Adults
Older People
Conditions and Lifestyle Factors
Coronavirus Infections
Mental Disorders
Settings
General Practice
Mental Health Outpatient Department
Staff Groups
Drug Therapy
Mental Health Nurse
Psychiatrist